Lipid metabolism and immunosuppressive therapy in heart transplant recipients.
Berman
M
M
Department of Cardiothoracic Surgery, Rabin Medical Center, Beilinson Campus, Israel. mariusby@yahoo.com
Ben-Gal
T
T
Stamler
A
A
Kogan
A
A
Shapira
Y
Y
Sagie
A
A
Saute
M
M
Kramer
M
M
Aravot
D
D
Vidne
B
B
Sahar
G
G
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D002784:Cholesterol / Q000097:blood*; D016572:Cyclosporine / Q000627:therapeutic use; D005500:Follow-Up Studies; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D006903:Hydroxymethylglutaryl CoA Reductases / Q000627:therapeutic use; D006949:Hyperlipidemias / Q000453:epidemiology*; D007165:Immunosuppression Therapy / Q000379:methods*; D011183:Postoperative Complications / Q000453:epidemiology; D012189:Retrospective Studies; D016559:Tacrolimus / Q000627:therapeutic use; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D016572:Cyclosporine; D002784:Cholesterol; D006903:Hydroxymethylglutaryl CoA Reductases; D016559:Tacrolimus